Amarin Corporation plc (AMRN)Healthcare | Drug Manufacturers - General | Dublin, Ireland | NasdaqCM
14.98 USD
+0.26
(1.766%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 15.20 +0.22 (1.469%) ⇧ (April 17, 2026, 5:25 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 2:50 p.m. EDT
Amarin Corporation (AMRN) appears to be in a state of uncertainty, with recent news and price movements showing a mix of positive and negative indicators. The stock has experienced some volatility, with recent dips and rallies, but the overall trend is not clearly upward. The recent earnings reports show some improvement in profitability, but the company continues to operate in a challenging environment. The lack of consistent dividend payouts makes it less attractive for income-focused investors. While there are some signs of potential momentum, the overall fundamentals and forecasting model suggest a cautious approach. Investors should consider the mixed signals from options activity and the recent price history before making any decisions. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.038705 |
| AutoETS | 0.056951 |
| AutoARIMA | 0.057040 |
| MSTL | 0.071293 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.59 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.705 |
| Excess Kurtosis | 0.11 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.791 |
| Revenue per Share | 10.297 |
| Market Cap | 314,174,496 |
| Forward P/E | 12.80 |
| Beta | 0.82 |
| Profit Margins | -18.16% |
| Website | https://www.amarincorp.com |
As of April 11, 2026, 2:50 p.m. EDT: Options speculators are showing mixed signals. For calls, there's a notable concentration of open interest (OI) and volume on out-of-the-money (OTM) strikes, especially for higher strike prices, which suggests some bullish sentiment. However, the high implied volatility (IV) on certain strikes, like the 30.0 and 35.0 strikes, indicates uncertainty or potential for significant price swings. On the puts side, there's a concentration of OI and volume on OTM strikes below the current price, which could signal caution or a bearish outlook. The presence of high IV on lower strikes, like the 3.0 strike, suggests some fear of a sharp decline. Overall, the options activity reflects a mix of caution and potential for volatility, with no clear consensus on the direction of the stock.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.56858635 |
| Address1 | One Central Plaza |
| Address2 | 8th Floor 36 Dame Street |
| All Time High | 28,500.0 |
| All Time Low | 7.0 |
| Ask | 15.24 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 53,920 |
| Average Daily Volume3 Month | 73,803 |
| Average Volume | 73,803 |
| Average Volume10Days | 53,920 |
| Beta | 0.821 |
| Bid | 14.58 |
| Bid Size | 1 |
| Book Value | 22.069 |
| City | Dublin |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Ireland |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 14.98 |
| Current Ratio | 3.342 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 15.1 |
| Day Low | 14.5964 |
| Debt To Equity | 1.791 |
| Display Name | Amarin |
| Earnings Call Timestamp End | 1,777,464,000 |
| Earnings Call Timestamp Start | 1,777,464,000 |
| Earnings Timestamp | 1,777,465,800 |
| Earnings Timestamp End | 1,777,465,800 |
| Earnings Timestamp Start | 1,777,465,800 |
| Ebitda | -10,913,000 |
| Ebitda Margins | -0.05108 |
| Enterprise To Ebitda | -544.168 |
| Enterprise To Revenue | 27.796 |
| Enterprise Value | 5,938,504,704 |
| Eps Current Year | 0.78 |
| Eps Forward | 1.17 |
| Eps Trailing Twelve Months | -1.8 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 14.842 |
| Fifty Day Average Change | 0.13799953 |
| Fifty Day Average Change Percent | 0.009297907 |
| Fifty Two Week Change Percent | 56.858635 |
| Fifty Two Week High | 20.9 |
| Fifty Two Week High Change | -5.92 |
| Fifty Two Week High Change Percent | -0.2832536 |
| Fifty Two Week Low | 8.94 |
| Fifty Two Week Low Change | 6.04 |
| Fifty Two Week Low Change Percent | 0.67561525 |
| Fifty Two Week Range | 8.94 - 20.9 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 733,674,600,000 |
| Float Shares | 367,422,845 |
| Forward Eps | 1.17 |
| Forward P E | 12.803419 |
| Free Cashflow | -25,504,500 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 80 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.56574 |
| Gross Profits | 120,868,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01972 |
| Held Percent Institutions | 0.22668 |
| Implied Shares Outstanding | 20,972,933 |
| Industry | Drug Manufacturers - General |
| Industry Disp | Drug Manufacturers - General |
| Industry Key | drug-manufacturers-general |
| Ir Website | http://investor.amarincorp.com/ |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,744,329,600 |
| Last Split Factor | 1:20 |
| Long Business Summary | Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. |
| Long Name | Amarin Corporation plc |
| Market | us_market |
| Market Cap | 314,174,496 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_407863 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -38,798,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 314,174,533 |
| Number Of Analyst Opinions | 2 |
| Open | 14.8 |
| Operating Cashflow | 6,728,000 |
| Operating Margins | -0.045939997 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.81 |
| Phone | 353 0 166 99020 |
| Post Market Change | 0.22000027 |
| Post Market Change Percent | 1.4686266 |
| Post Market Price | 15.2 |
| Post Market Time | 1,776,461,128 |
| Previous Close | 14.72 |
| Price Eps Current Year | 19.205128 |
| Price Hint | 2 |
| Price To Book | 0.67878014 |
| Price To Sales Trailing12 Months | 1.4705377 |
| Profit Margins | -0.1816 |
| Quick Ratio | 2.208 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.259999 |
| Regular Market Change Percent | 1.7663 |
| Regular Market Day High | 15.1 |
| Regular Market Day Low | 14.5964 |
| Regular Market Day Range | 14.5964 - 15.1 |
| Regular Market Open | 14.8 |
| Regular Market Previous Close | 14.72 |
| Regular Market Price | 14.98 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 62,825 |
| Return On Assets | -0.01285 |
| Return On Equity | -0.08207 |
| Revenue Growth | -0.21 |
| Revenue Per Share | 10.297 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 20,972,933 |
| Shares Percent Shares Out | 0.0217 |
| Shares Short | 455,457 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 438,392 |
| Short Name | Amarin Corporation plc |
| Short Percent Of Float | 0.0221 |
| Short Ratio | 7.11 |
| Source Interval | 15 |
| Symbol | AMRN |
| Target High Price | 12.0 |
| Target Low Price | 12.0 |
| Target Mean Price | 12.0 |
| Target Median Price | 12.0 |
| Total Cash | 302,588,992 |
| Total Cash Per Share | 0.727 |
| Total Debt | 8,228,000 |
| Total Revenue | 213,646,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.8 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 15.6124 |
| Two Hundred Day Average Change | -0.6324005 |
| Two Hundred Day Average Change Percent | -0.040506296 |
| Type Disp | Equity |
| Volume | 62,825 |
| Website | https://www.amarincorp.com |
| Zip | D02 K7K5 |